Efficacy and nutritional status of InBodyTM in diagnosis of presarcopenia and sarcopenia

Efficacy and nutritional status of InBodyTM in diagnosis of presarcopenia and sarcopenia - Efficacy and nutritional status of InBodyTM in diagnosis of presarcopenia and sarcopenia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025790

Enrollment

Registered

2017-01-21

Start date

2017-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic liver disease who are 20 or more years old Patients with ECOG PS 0 or 1 Patient who is a chronic liver disease patient and has participated in this study fully enough to explain themselves before the start of the research and obtained consent form by themselves. Patients who are pregnant or nursing and who have no possibility or willingness to become pregnant (perform a pregnancy test if there is suspected pregnancy)

Exclusion criteria

Exclusion criteria: 1)Patients who actually have hepatic encephalopathy with coma classification II or more. 2)Patients with congenital branched-chain amino acid metabolism abnormalities.

Design outcomes

Primary

Measure	Time frame
To evaluate the prevalence of presarcopenia and sarcopenia in patients with chronic liver disease	—

Countries

Japan

Contacts

Public Contactmasashi kono

Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine

kono@med.kindai.ac.jp09084560416

Outcome results